Data Suggest Denufosol May Hold Promise as an Early Intervention Treatment for Cystic Fibrosis

Data Suggest Denufosol May Hold Promise as an Early Intervention Treatment for Cystic Fibrosis
DURHAM, N.C.—-Inspire Pharmaceuticals, Inc. announced today that Inspire scientists and collaborators will present data on denufosol tetrasodium, an investigational therapy for cystic fibrosis , during an oral presentation at the American Thoracic Society 2010 International Conference May 14 – 19, 2010 in New Orleans, LA.

Read more on Business Wire via Yahoo! Finance

More Meth Drug Addiction Info: